South Carolina Statutes
§ 44-53-1830 — Cannabidiol for use in clinical trials.
(A)Expanded access clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to this chapter only shall utilize cannabidiol which is:
(1)from an approved source; and (2) approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application.
(B)The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the expanded access clinical trials.
Free access — add to your briefcase to read the full text and ask questions with AI
South Carolina § 44-53-1830 (Cannabidiol for use in clinical trials.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
HISTORY: 2014 Act No. 221 (S.1035), SECTION 2, eff June 2, 2014.
Nearby Sections
15
§ 44-53-10
General powers of Department of Health and Environmental Control regarding controlled substances.§ 44-53-110
Definitions.§ 44-53-1130
Penalties.§ 44-53-120
Duties of State Law Enforcement Division.§ 44-53-1210
Definitions.§ 44-53-1220
Sale of caustic or corrosive substance in misbranded parcel, package, or container prohibited.§ 44-53-1230
Confiscation of misbranded caustic or corrosive substance parcels, packages, or containers.§ 44-53-1240
Enforcement; approval of brands and labels.§ 44-53-1250
Penalties.§ 44-53-130
Coordination of law enforcement.§ 44-53-1310
Short title.§ 44-53-1320
Definitions.§ 44-53-1350
Exemptions.